Age-related autonomous aldosteronism

Circulation

Volumn 136, Issue 4, 2017, Pages 347-355

  Nanba, Kazutaka ^a   Vaidya, Anand ^b   Williams, Gordon H ^b   Zheng, Isabel ^a   Else, Tobias ^a   Rainey, William E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

aging; aldosterone; aldosterone producing cell cluster; cytochrome P 450 CYP11B2; primary aldosteronism; renin

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; RENIN;

ADRENAL GLAND; ADRENAL GLAND TISSUE; ADULT; AGE RELATED AUTONOMOUS ALDOSTERONISM; AGED; ALDOSTERONE URINE LEVEL; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPERALDOSTERONISM; IMMUNOHISTOCHEMISTRY; KIDNEY DONOR; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BALANCE; SODIUM RESTRICTION; ADOLESCENT; AGE; AGING; BIOSYNTHESIS; CHILD; INFANT; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADRENAL GLANDS; ADULT; AGE FACTORS; AGED; AGING; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP11B2; FEMALE; HUMANS; HYPERALDOSTERONISM; INFANT; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 85020184863     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.028201     Document Type: Article

References (36)

1. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008; 168: 80-85. doi: 10.1001/archinternmed. 2007.33.
2. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005; 45: 1243-1248. doi: 10.1016/j.jacc.2005.01.015.
3. Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, Crudo V, Burrello J, Milan A, Rabbia F, Veglio F. Long-Term cardioand cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013; 98: 4826-4833. doi: 10.1210/jc.2013-2805.
4. Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013; 62: 331-336. doi: 10.1161/HYPERTENSIONAHA. 113.01060.
5. Hattangady NG, Olala LO, Bollag WB, Rainey WE. Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol. 2012; 350: 151-162. doi: 10.1016/j.mce.2011.07.034.
6. Bassett MH, White PC, Rainey WE. The regulation of aldosterone synthase expression. Mol Cell Endocrinol. 2004; 217: 67-74. doi: 10.1016/j.mce.2003.10.011.
7. Condon JC, Pezzi V, Drummond BM, Yin S, Rainey WE. Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology. 2002; 143: 3651-3657. doi: 10.1210/en.2001-211359.
8. Nogueira EF, Xing Y, Morris CA, Rainey WE. Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis. J Mol Endocrinol. 2009; 42: 319-330. doi: 10.1677/JME-08-0112.
9. Nogueira EF, Bollag WB, Rainey WE. Angiotensin II regulation of adrenocortical gene transcription. Mol Cell Endocrinol. 2009; 302: 230-236. doi: 10.1016/j.mce.2008.08.024.
10. Nanba K, Chen A, Nishimoto K, Rainey WE. Role of Ca(2+)/calmodulindependent protein kinase kinase in adrenal aldosterone production. Endocrinology. 2015; 156: 1750-1756. doi: 10.1210/en.2014-1782.
11. Weidmann P, De Myttenaere-Bursztein S, Maxwell MH, de Lima J. Effect on aging on plasma renin and aldosterone in normal man. Kidney Int. 1975; 8: 325-333.
12. Crane MG, Harris JJ. Effect of aging on renin activity and aldosterone excretion. J Lab Clin Med. 1976; 87: 947-959.
13. Hegstad R, Brown RD, Jiang NS, Kao P, Weinshilboum RM, Strong C, Wisgerhof M. Aging and aldosterone. Am J Med. 1983; 74: 442-448.
14. Tsunoda K, Abe K, Goto T, Yasujima M, Sato M, Omata K, Seino M, Yoshinaga K. Effect of age on the renin-Angiotensin-Aldosterone system in normal subjects: simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma. J Clin Endocrinol Metab. 1986; 62: 384-389. doi: 10.1210/jcem-62-2-384.
15. Kerstens MN, Kobold AC, Volmer M, Koerts J, Sluiter WJ, Dullaart RP. Reference values for aldosterone-renin ratios in normotensive individuals and effect of changes in dietary sodium consumption. Clin Chem. 2011; 57: 1607-1611. doi: 10.1373/clinchem.2011.165662.
16. Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, Rainey W, Satoh F, Maekawa T, Nakamura Y, Sasano H, Gomez-Sanchez EP. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol. 2014; 383: 111-117. doi: 10.1016/j.mce.2013.11.022.
17. Nishimoto K, Nakagawa K, Li D, Kosaka T, Oya M, Mikami S, Shibata H, Itoh H, Mitani F, Yamazaki T, Ogishima T, Suematsu M, Mukai K. Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab. 2010; 95: 2296-2305. doi: 10.1210/jc.2009-2010.
18. Nanba K, Tsuiki M, Sawai K, Mukai K, Nishimoto K, Usui T, Tagami T, Okuno H, Yamamoto T, Shimatsu A, Katabami T, Okumura A, Kawa G, Tanabe A, Naruse M. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. J Clin Endocrinol Metab. 2013; 98: 1567-1574. doi: 10.1210/jc.2012-3726.
19. Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol Cell Endocrinol. 2015; 411: 146-154. doi: 10.1016/j.mce.2015.04.022.
20. Ono Y, Nakamura Y, Maekawa T, Felizola SJ, Morimoto R, Iwakura Y, Kudo M, Seiji K, Takase K, Arai Y, Gomez-Sanchez CE, Ito S, Sasano H, Satoh F. Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas. Hypertension. 2014; 64: 438-444. doi: 10.1161/HYPERTENSIONAHA. 113.02944.
21. Nanba K, Chen AX, Omata K, Vinco M, Giordano TJ, Else T, Hammer GD, Tomlins SA, Rainey WE. Molecular heterogeneity in aldosteroneproducing adenomas. J Clin Endocrinol Metab. 2016; 101: 999-1007. doi: 10.1210/jc.2015-3239.
22. Nishimoto K, Tomlins SA, Kuick R, Cani AK, Giordano TJ, Hovelson DH, Liu CJ, Sanjanwala AR, Edwards MA, Gomez-Sanchez CE, Nanba K, Rainey WE. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci U S A. 2015; 112: E4591-E4599. doi: 10.1073/pnas.1505529112.
23. Lalli E, Barhanin J, Zennaro MC, Warth R. Local control of aldosterone production and primary aldosteronism. Trends Endocrinol Metab. 2016; 27: 123-131. doi: 10.1016/j.tem.2016.01.003.
24. Underwood PC, Chamarthi B, Williams JS, Vaidya A, Garg R, Adler GK, Grotzke MP, Staskus G, Wadwekar D, Hopkins PN, Ferri C, McCall A, Mc-Clain D, Williams GH. Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012; 97: 3775-3782. doi: 10.1210/jc.2012-2127.
25. Vaidya A, Underwood PC, Hopkins PN, Jeunemaitre X, Ferri C, Williams GH, Adler GK. Abnormal aldosterone physiology and cardiometabolic risk factors. Hypertension. 2013; 61: 886-893. doi: 10.1161/HYPERTENSIONAHA. 111.00662.
26. Brown JM, Underwood PC, Ferri C, Hopkins PN, Williams GH, Adler GK, Vaidya A. Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk. Hypertension. 2014; 63: 1205-1211. doi: 10.1161/HYPERTENSIONAHA.114.03231.
27. Xing Y, Lerario AM, Rainey W, Hammer GD. Development of adrenal cortex zonation. Endocrinol Metab Clin North Am. 2015; 44: 243-274. doi: 10.1016/j.ecl.2015.02.001.
28. Ishimoto H, Jaffe RB. Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit. Endocr Rev. 2011; 32: 317-355. doi: 10.1210/er.2010-0001.
29. Spitzer A. The role of the kidney in sodium homeostasis during maturation. Kidney Int. 1982; 21: 539-545.
30. Robillard JE, Smith FG. Endocrine control of electrolyte balance during development. Baillieres Clin Endocrinol Metab. 1989; 3: 659-669.
31. Dekkers T, ter Meer M, Lenders JW, Hermus AR, Schultze Kool L, Langenhuijsen JF, Nishimoto K, Ogishima T, Mukai K, Azizan EA, Tops B, Deinum J, Küsters B. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? J Clin Endocrinol Metab. 2014; 99: E1341-E1351. doi: 10.1210/jc.2013-4255.
32. Baudrand R, Guarda FJ, Fardella C, Hundemer G, Brown J, Williams G, Vaidya A. Continuum of renin-independent aldosteronism in normotension. Hypertension. 2017; 69: 950-956. doi: 10.1161/HYPERTENSIONAHA.116.08952.
33. Markou A, Pappa T, Kaltsas G, Gouli A, Mitsakis K, Tsounas P, Prevoli A, Tsiavos V, Papanastasiou L, Zografos G, Chrousos GP, Piaditis GP. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension. J Clin Endocrinol Metab. 2013; 98: 1409-1416. doi: 10.1210/jc.2012-3353.
34. Tu W, Eckert GJ, Hannon TS, Liu H, Pratt LM, Wagner MA, Dimeglio LA, Jung J, Pratt JH. Racial differences in sensitivity of blood pressure to aldosterone. Hypertension. 2014; 63: 1212-1218. doi: 10.1161/HYPERTENSIONAHA. 113.02989.
35. Grim CE, Cowley AW Jr, Hamet P, Gaudet D, Kaldunski ML, Kotchen JM, Krishnaswami S, Pausova Z, Roman R, Tremblay J, Kotchen TA. Hyperaldosteronism and hypertension: ethnic differences. Hypertension. 2005; 45: 766-772. doi: 10.1161/01.HYP.0000154364.00763.d5.
36. Richardson SI, Freedman BI, Ellison DH, Rodriguez CJ. Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics. J Am Soc Hypertens. 2013; 7: 170-179. doi: 10.1016/j.jash.2013.01.003.